Human leukocyte antigen-associated drug hypersensitivity

详细信息    查看全文

• 作者：Patricia T Illing¹ ; Julian P Vivian² ; Anthony W Purcell³ ; ⁶ ; Jamie Rossjohn² ; ⁴ ; ^{Jamie.rossjohn@monash.edu} ; James McCluskey¹ ; ⁵ ; ^{jamesm1@unimelb.edu.au}
• 刊名：Current Opinion in Immunology
• 出版年：2013
• 出版时间：February, 2013
• 年：2013
• 卷：25
• 期：1
• 页码：81-89
• 全文大小：1103 K

文摘

A growing number of associations between adverse drug reactions and alleles of the human leukocyte antigen (HLA) genes are now known. Although several models have been proposed to explain these associations, an underlying molecular basis has only recently been described. The associations between HLA-B*57:01 and abacavir hypersensitivity syndrome, and HLA-B*15:02 and carbamazepine-induced bullous skin disease have provided new insights into the mechanism associated with hypersensitivity reactions to these drugs. Here we discuss recent evidence that small molecules can interact with specific HLA to distort self-peptide presentation leading to autoimmune-like drug hypersensitivities that potentially provide clues to the mechanisms underlying other immunopathologies.